Central melanocortins and the regulation of weight during acute and chronic disease

Daniel Marks, Roger D. Cone

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Recent advances in our understanding of the regulation of body weight, appetite, and metabolic rate have highlighted the role of the adipose-derived hormone leptin and its receptor as fundamental modulators of these processes. Investigations of the neural targets for leptin action - as well as characterization of the agouti obesity syndrome - have, in turn, led to the discovery of fundamental neural pathways involved in the central regulation of energy homeostasis. In particular, the central melanocortin system has been shown to regulate appetite and metabolic rate in rodents; mutations in this system have been demonstrated to result in obesity in humans. Overall, the melanocortin system appears to function as a bidirectional rheostat in the regulation of energy intake and expenditure in rodents and potentially in humans. The first section of this chapter will focus on the development of our understanding of melanocortin physiology in the context of obesity. In particular, recent data regarding the interplay between melanocortin and neuropeptide Y (NPY) signaling at a cellular level will be discussed. The following section will discuss the hypothesis that melanocortin signaling plays a role in pathological weight loss and hypermetabolism observed in murine cachexia models. The potential role of this system in integrating a variety of anorexic and cachexic signals, as well as the potential for its pharmacological manipulation in the treatment of human cachexia, will be discussed.

Original languageEnglish (US)
Pages (from-to)359-375
Number of pages17
JournalRecent Progress in Hormone Research
Volume56
DOIs
StatePublished - 2001

Fingerprint

Melanocortins
Acute Disease
Chronic Disease
Weights and Measures
Cachexia
Obesity
Appetite
Rodentia
Leptin Receptors
Neural Pathways
Neuropeptide Y
Leptin
Energy Intake
Energy Metabolism
Weight Loss
Homeostasis
Body Weight
Hormones
Pharmacology
Mutation

ASJC Scopus subject areas

  • Endocrinology

Cite this

Central melanocortins and the regulation of weight during acute and chronic disease. / Marks, Daniel; Cone, Roger D.

In: Recent Progress in Hormone Research, Vol. 56, 2001, p. 359-375.

Research output: Contribution to journalArticle

@article{92852dd15e61462b977f47a12d9a5079,
title = "Central melanocortins and the regulation of weight during acute and chronic disease",
abstract = "Recent advances in our understanding of the regulation of body weight, appetite, and metabolic rate have highlighted the role of the adipose-derived hormone leptin and its receptor as fundamental modulators of these processes. Investigations of the neural targets for leptin action - as well as characterization of the agouti obesity syndrome - have, in turn, led to the discovery of fundamental neural pathways involved in the central regulation of energy homeostasis. In particular, the central melanocortin system has been shown to regulate appetite and metabolic rate in rodents; mutations in this system have been demonstrated to result in obesity in humans. Overall, the melanocortin system appears to function as a bidirectional rheostat in the regulation of energy intake and expenditure in rodents and potentially in humans. The first section of this chapter will focus on the development of our understanding of melanocortin physiology in the context of obesity. In particular, recent data regarding the interplay between melanocortin and neuropeptide Y (NPY) signaling at a cellular level will be discussed. The following section will discuss the hypothesis that melanocortin signaling plays a role in pathological weight loss and hypermetabolism observed in murine cachexia models. The potential role of this system in integrating a variety of anorexic and cachexic signals, as well as the potential for its pharmacological manipulation in the treatment of human cachexia, will be discussed.",
author = "Daniel Marks and Cone, {Roger D.}",
year = "2001",
doi = "10.1210/rp.56.1.359",
language = "English (US)",
volume = "56",
pages = "359--375",
journal = "Recent Progress in Hormone Research",
issn = "0079-9963",
publisher = "The Endocrine Society",

}

TY - JOUR

T1 - Central melanocortins and the regulation of weight during acute and chronic disease

AU - Marks, Daniel

AU - Cone, Roger D.

PY - 2001

Y1 - 2001

N2 - Recent advances in our understanding of the regulation of body weight, appetite, and metabolic rate have highlighted the role of the adipose-derived hormone leptin and its receptor as fundamental modulators of these processes. Investigations of the neural targets for leptin action - as well as characterization of the agouti obesity syndrome - have, in turn, led to the discovery of fundamental neural pathways involved in the central regulation of energy homeostasis. In particular, the central melanocortin system has been shown to regulate appetite and metabolic rate in rodents; mutations in this system have been demonstrated to result in obesity in humans. Overall, the melanocortin system appears to function as a bidirectional rheostat in the regulation of energy intake and expenditure in rodents and potentially in humans. The first section of this chapter will focus on the development of our understanding of melanocortin physiology in the context of obesity. In particular, recent data regarding the interplay between melanocortin and neuropeptide Y (NPY) signaling at a cellular level will be discussed. The following section will discuss the hypothesis that melanocortin signaling plays a role in pathological weight loss and hypermetabolism observed in murine cachexia models. The potential role of this system in integrating a variety of anorexic and cachexic signals, as well as the potential for its pharmacological manipulation in the treatment of human cachexia, will be discussed.

AB - Recent advances in our understanding of the regulation of body weight, appetite, and metabolic rate have highlighted the role of the adipose-derived hormone leptin and its receptor as fundamental modulators of these processes. Investigations of the neural targets for leptin action - as well as characterization of the agouti obesity syndrome - have, in turn, led to the discovery of fundamental neural pathways involved in the central regulation of energy homeostasis. In particular, the central melanocortin system has been shown to regulate appetite and metabolic rate in rodents; mutations in this system have been demonstrated to result in obesity in humans. Overall, the melanocortin system appears to function as a bidirectional rheostat in the regulation of energy intake and expenditure in rodents and potentially in humans. The first section of this chapter will focus on the development of our understanding of melanocortin physiology in the context of obesity. In particular, recent data regarding the interplay between melanocortin and neuropeptide Y (NPY) signaling at a cellular level will be discussed. The following section will discuss the hypothesis that melanocortin signaling plays a role in pathological weight loss and hypermetabolism observed in murine cachexia models. The potential role of this system in integrating a variety of anorexic and cachexic signals, as well as the potential for its pharmacological manipulation in the treatment of human cachexia, will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=0035786901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035786901&partnerID=8YFLogxK

U2 - 10.1210/rp.56.1.359

DO - 10.1210/rp.56.1.359

M3 - Article

C2 - 11237221

AN - SCOPUS:0035786901

VL - 56

SP - 359

EP - 375

JO - Recent Progress in Hormone Research

JF - Recent Progress in Hormone Research

SN - 0079-9963

ER -